In this week’s pharmaphorum digital health round-up we look at Akili’s therapeutic video game, the unveiling of next-gen medical imaging tech by NVIDIA, a new blockcha
Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist.